CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation

Journal of Cell Biology

Volumn 208, Issue 7, 2015, Pages 987-1001

  Draheim, Kyle M ^a   Li, Xiaofeng ^a   Zhang, Rong ^a   Fisher, Oriana S ^a   Villari, Giulia ^a   Boggon, Titus J ^a   Calderwood, David A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CEREBRAL CAVERNOUS MALFORMATION 2 PROTEIN; CEREBRAL CAVERNOUS MALFORMATION 3 PROTEIN; HETEROCHROMATIN PROTEIN 1; LYSINE; PAXILLIN; PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CCM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PDCD10 PROTEIN, HUMAN; PROTEIN BINDING; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENDOTHELIAL NETWORK FORMATION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; FOCAL ADHESION; HUMAN; HUMAN CELL; HYDROGEN BOND; IMMUNOBLOTTING; MAMMAL CELL; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; ANGIOGENESIS; BINDING SITE; BRAIN HEMANGIOMA; CELL LINE; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENETICS; METABOLISM; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; ULTRASTRUCTURE; VASCULARIZATION;

APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CARRIER PROTEINS; CELL LINE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CRYSTALLOGRAPHY, X-RAY; GENE EXPRESSION; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PAXILLIN; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT;

EID: 84928251809     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201407129     Document Type: Article

References (39)

1. Adams, P.D., P.V. Afonine, G. Bunkóczi, V.B. Chen, I.W. Davis, N. Echols, J.J. Headd, L.W. Hung, G.J. Kapral, R.W. Grosse-Kunstleve, et al. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221. http://dx.doi.org/10.1107/S0907444909052925
2. Alam, T., M. Alazmi, X. Gao, and S.T. Arold. 2014. How to find a leucine in a haystack? Structure, ligand recognition and regulation of leucineaspartic acid (LD) motifs. Biochem. J. 460:317-329. http://dx.doi.org/10.1042/BJ20140298
3. Bond, C.S., and A.W. Schüttelkopf. 2009. ALINE: a WYSIWYG proteinsequence alignment editor for publication-quality alignments. Acta Crystallogr. D Biol. Crystallogr. 65:510-512. http://dx.doi.org/10.1107/S0907444909007835
4. Borikova, A.L., C.F. Dibble, N. Sciaky, C.M. Welch, A.N. Abell, S. Bencharit, and G.L. Johnson. 2010. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J. Biol. Chem. 285:11760-11764. http://dx.doi.org/10.1074/jbc.C109.097220
5. Bouïs, D., G.A. Hospers, C. Meijer, G. Molema, and N.H. Mulder. 2001. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis. 4:91-102. http://dx.doi .org/10.1023/A:1012259529167
6. Chan, A.C., D.Y. Li, M.J. Berg, and K.J. Whitehead. 2010. Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS J. 277:1076-1083. http://dx.doi.org/10.1111/j.1742-4658.2009.07536.x
7. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763. http://dx.doi.org/10.1107/S0907444994003112
8. Davis, I.W., L.W. Murray, J.S. Richardson, and D.C. Richardson. 2004. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32:W615-W619. http://dx.doi.org/10.1093/nar/gkh398
9. Draheim, K.M., O.S. Fisher, T.J. Boggon, and D.A. Calderwood. 2014. Cerebral cavernous malformation proteins at a glance. J. Cell Sci. 127:701-707. http://dx.doi.org/10.1242/jcs.138388
10. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. http://dx .doi.org/10.1107/S0907444904019158
11. Faurobert, E., C. Rome, J. Lisowska, S. Manet-Dupé, G. Boulday, M. Malbouyres, M. Balland, A.P. Bouin, M. Kéramidas, D. Bouvard, et al. 2013. CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling. J. Cell Biol. 202:545-561.
12. Fidalgo, M., A. Guerrero, M. Fraile, C. Iglesias, C.M. Pombo, and J. Zalvide. 2012. Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress. J. Biol. Chem. 287:11556-11565. http://dx.doi.org/10.1074/jbc.M111.320259
13. Fisher, O.S., and T.J. Boggon. 2014. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell. Mol. Life Sci. 71:1881-1892. http://dx.doi.org/10.1007/s00018-013-1532-9
14. Fisher, O.S., R. Zhang, X. Li, J.W. Murphy, B. Demeler, and T.J. Boggon. 2013. Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus. FEBS Lett. 587:272-277. http://dx.doi.org/10.1016/j.febslet.2012.12.011
15. Fisher, O.S., W. Liu, R. Zhang, A.L. Stiegler, S. Ghedia, J.L. Weber, and T.J. Boggon. 2015. Structural basis for the disruption of the Cerebral Cavernous Malformations 2 (CCM2) interaction with Krev Interaction Trapped 1 (KRIT1) by disease-associated mutations. J. Biol. Chem. 290: 2842-2853. http://dx.doi.org/10.1074/jbc.M114.616433
16. Fu, C., D.R. Wehr, J. Edwards, and B. Hauge. 2008. Rapid one-step recombinational cloning. Nucleic Acids Res. 36:e54. http://dx.doi.org/10.1093/nar/gkn167
17. Girish, V., and A. Vijayalakshmi. 2004. Affordable image analysis using NIH Image/ImageJ. Indian J. Cancer. 41:47.
18. Gordon, J., J. Hwang, K.J. Carrier, C.A. Jones, Q.L. Kern, C.S. Moreno, R.H. Karas, and D.C. Pallas. 2011. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem. 12:54. http://dx.doi.org/10.1186/1471-2091-12-54
19. Goudreault, M., L.M. D'Ambrosio, M.J. Kean, M.J. Mullin, B.G. Larsen, A. Sanchez, S. Chaudhry, G.I. Chen, F. Sicheri, A.I. Nesvizhskii, et al. 2009. A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell. Proteomics. 8:157-171. http://dx.doi.org/10.1074/mcp.M800266-MCP200
20. Hoellerer, M.K., M.E. Noble, G. Labesse, I.D. Campbell, J.M. Werner, and S.T. Arold. 2003. Molecular recognition of paxillin LD motifs by the focal adhesion targeting domain. Structure. 11:1207-1217. http://dx.doi.org/10.1016/j.str.2003.08.010
21. Hogan, B.M., J. Bussmann, H. Wolburg, and S. Schulte-Merker. 2008. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 17:2424-2432. http://dx.doi.org/10.1093/hmg/ddn142
22. Jones, M.K., I.J. Sarfeh, and A.S. Tarnawski. 1998. Induction of in vitro angiogenesis in the endothelial-derived cell line, EA hy926, by ethanol is mediated through PKC and MAPK. Biochem. Biophys. Res. Commun. 249:118-123. http://dx.doi.org/10.1006/bbrc.1998.9095
23. Kean, M.J., D.F. Ceccarelli, M. Goudreault, M. Sanches, S. Tate, B. Larsen, L.C. Gibson, W.B. Derry, I.C. Scott, L. Pelletier, et al. 2011. Structure-function analysis of core STRIPAK Proteins: a signaling complex implicated in Golgi polarization. J. Biol. Chem. 286:25065-25075. http://dx.doi.org/10.1074/jbc.M110.214486
24. Kemp, H.A., and G.F. Sprague Jr. 2003. Far3 and five interacting proteins prevent premature recovery from pheromone arrest in the budding yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 23:1750-1763. http://dx.doi .org/10.1128/MCB.23.5.1750-1763.2003
25. Kiema, T., Y. Lad, P. Jiang, C.L. Oxley, M. Baldassarre, K.L. Wegener, I.D. Campbell, J. Ylänne, and D.A. Calderwood. 2006. The molecular basis of filamin binding to integrins and competition with talin. Mol. Cell. 21:337-347. http://dx.doi.org/10.1016/j.molcel.2006.01.011
26. Krissinel, E., and K. Henrick. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022
27. Li, X., R. Zhang, H. Zhang, Y. He, W. Ji, W. Min, and T.J. Boggon. 2010. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J. Biol. Chem. 285:24099-24107. http://dx.doi.org/10.1074/jbc.M110.128470
28. Li, X., W. Ji, R. Zhang, E. Folta-Stogniew, W. Min, and T.J. Boggon. 2011. Molecular recognition of leucine-aspartate repeat (LD) motifs by the FAThomology domain of cerebral cavernous malformation 3 (CCM3). J. Biol. Chem. 286:26138-26147. http://dx.doi.org/10.1074/jbc.M110.211250
29. Liquori, C.L., M.J. Berg, A.M. Siegel, E. Huang, J.S. Zawistowski, T. Stoffer, D. Verlaan, F. Balogun, L. Hughes, T.P. Leedom, et al. 2003. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73:1459-1464. http://dx.doi.org/10.1086/380314
30. Lulo, J., S. Yuzawa, and J. Schlessinger. 2009. Crystal structures of free and ligandbound focal adhesion targeting domain of Pyk2. Biochem. Biophys. Res. Commun. 383:347-352. http://dx.doi.org/10.1016/j.bbrc.2009.04.011
31. McCoy, A.J., R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, and R.J. Read. 2007. Phaser crystallographic software. J. Appl. Cryst. 40:658-674. http://dx.doi.org/10.1107/S0021889807021206
32. McNicholas, S., E. Potterton, K.S. Wilson, and M.E. Noble. 2011. Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr. D Biol. Crystallogr. 67:386-394. http://dx.doi.org/10.1107/S0907444911007281
33. Murshudov, G.N., P. Skubák, A.A. Lebedev, N.S. Pannu, R.A. Steiner, R.A. Nicholls, M.D. Winn, F. Long, and A.A. Vagin. 2011. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67:355-367. http://dx.doi.org/10.1107/S0907444911001314
34. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326. http://dx.doi.org/10.1016/S0076-6879(97)76066-X
35. Riant, F., F. Bergametti, H.D. Fournier, F. Chapon, S. Michalak-Provost, M. Cecillon, P. Lejeune, H. Hosseini, C. Choe, M. Orth, et al. 2013. CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas. Mol. Syndromol. 4:165-172.
36. Sugden, P.H., L.J. McGuffin, and A. Clerk. 2013. SOcK, MiSTs, MASK and STicKs: the GCKIII (germinal centre kinase III) kinases and their heterologous protein-protein interactions. Biochem. J. 454:13-30. http://dx.doi.org/10.1042/BJ20130219
37. Voss, K., S. Stahl, E. Schleider, S. Ullrich, J. Nickel, T.D. Mueller, and U. Felbor. 2007. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics. 8:249-256. http://dx.doi.org/10.1007/s10048-007-0098-9
38. Wüstehube, J., A. Bartol, S.S. Liebler, R. Brütsch, Y. Zhu, U. Felbor, U. Sure, H.G. Augustin, and A. Fischer. 2010. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTANOTCH signaling. Proc. Natl. Acad. Sci. USA. 107:12640-12645. http://dx.doi.org/10.1073/pnas.1000132107
39. Zheng, X., C. Xu, A.O. Smith, A.N. Stratman, Z. Zou, B. Kleaveland, L. Yuan, C. Didiku, A. Sen, X. Liu, et al. 2012. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev. Cell. 23:342-355. http://dx.doi.org/10.1016/j.devcel.2012.06.004